Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 8/20 | 0.41 |
| ▸ | SYK | P43405 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | BACE1 | P56817 | 1/20 | 0.40 |
| ▸ | STS | P08842 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.38 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27147067 | 0.92 | P2RX7 (0.41) | P2RX7SYKMEN1KMT2ABACE1 | |
| SCHEMBL17608882 | 0.90 | P2RX7 (0.44) | P2RX7MEN1KMT2ABACE1STS | |
| SCHEMBL28865052 | 0.86 | SYK (0.44) | P2RX7SYKMEN1KMT2ABACE1 | |
| SCHEMBL26090865 | 0.85 | SYK (0.43) | P2RX7SYKMEN1KMT2ABACE1 | |
| SCHEMBL23390522 | 0.82 | STS (0.43) | P2RX7SYKMEN1KMT2ABACE1 | |
| SCHEMBL22041814 | 0.81 | CTSB (0.48) | P2RX7SYKMEN1KMT2ABACE1 | |
| SCHEMBL24940830 | 0.80 | MEN1 (0.43) | P2RX7SYKMEN1KMT2ABACE1 | |
| SCHEMBL30681417 | 0.80 | P2RX7 (0.41) | P2RX7SYKMEN1KMT2ABACE1 | |
| SCHEMBL26090864 | 0.80 | HTT (0.47) | P2RX7SYKMEN1KMT2ABACE1 | |
| SCHEMBL30732662 | 0.80 | MEN1 (0.42) | P2RX7SYKMEN1KMT2ABACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024044731-A1 | DIAZEPINO-THIENO-QUINOXALINE COMPOUNDS AND THEIR USE IN THERAPY | MATCHPOINT THERAPEUTICS INC. (US) | 2024-02-29 | — | — | WO | disclosed |